Navigation Links
Global conference on stem cell therapy for heart disease to be held Jan. 25-27 in NYC

WHAT: The Seventh International Conference on Cell Therapy for Cardiovascular Disease sponsored by the Cardiovascular Research Foundation (CRF) is a comprehensive program dedicated to the evolving field of cell-based therapies for the repair and regeneration of cardiac and vascular disease, as well as related diseases such as diabetes and stroke. This year's conference will focus on preclinical and clinical studies on the path to commercialization, highlighting the status of molecular, cell, and tissue products in addition to delivery systems.

Noteworthy presentations include a potential role for cell therapy in metabolic syndrome, large-scale studies in patients with heart failure and ST segment elevation myocardial infarction (STEMI) and early phase studies with new biologics involving endometrial cells.

Conference Highlights Include:

  • Periadventitial MAPC Administration in STEMI: Results and Phase II Study
    Thursday, January 26, 2012; 9:00 AM

    Drs. Marc Penn and Warren Sherman will present 1-year results of a Phase 1 clinical trial involving an allogeneic bone marrowderived adherent adult stem cell product in patients with first ST-elevationmyocardial infarction (STEMI). Preliminary 4-month results were recently published in the journal, Circulation Research: Investigators will also describe the Phase 2 trial scheduled to begin later this year.

  • SCIPIO: Autologous Cardiac-Derived Stem Cells for LV Dysfunction
    Thursday, January 26, 2012; 1:10 PM

    Dr. Roberto Bolli will present new data on cardiac MRI analyses, as well as, surgical feasibility and safety data from the SCIPIO trial. SCIPIO is a first-in-human, Phase 1, randomized trial of autologous c-kit+ cardiac stem cells (CSCs) in patients with ischemic cardiomyopathy and heart failure. Initial results published in The Lancet showed that intracoronary infusion of autologous CSCs results in a striking improvement in left ventricular ejection fraction, NYHA functional class, quality of life, and in a significant reduction in infarct size.

  • CD34+ Cells for Refractory Angina: ACT 34 CMI Update and Phase 3 Study Design
    Thursday, January 26, 2012; 10:45 AM

    Dr. Timothy Henry will discuss results of the ACT 34 trial, the largest randomized, placebo-controlled, double-blind trial of CD34+ cell therapy for the treatment of patients with class III/IV refractory angina. Dr. Henry will also discuss the study design of a planned Phase III trial set to begin in 2012.

  • SDF-1 for Heart Failure: Results of a Phase I Trial
    Thursday, January 26, 2012; 1:30 PM

    Dr. Marc Penn will present 1-year clinical data results of a plasmid encoding human SDF-1 protein in patients with chronic heart failure. SDF-1 has been identified as a key regulator of stem cell trafficking to sites of cardiac injury and could potentially be used to treat chronic heart failure. Investigators initially found that after four months, patients exhibited clinically significant improvements in quality of life, six-minute walk distance, decreased heart failure symptoms and stabilization of myocardial function.

The latest conference agenda is available at

WHY: Now in its 11th year of clinical trials, the application of stem cells in the treatment of cardiovascular diseases has seen many notable successes, as well as identified challenges that await the next round of clinical studies. Leaders in the field will convene to present their work, experiences, observations, and opinions on the benefits and unmet challenges of cell-based therapies.

In addition, Friday's sessions will focus on developing a rational policy towards stem cell study and utilization. Leading experts will also explore the benefits and drawbacks of stem cell tourism.

Course Director
Warren Sherman, MD
New York-Presbyterian Hospital/Columbia University Medical Center
New York, NY

Course Co-Directors
Josef Bartunek, MD, PhD
Cardiovascular Center, OLV Hospital
Aalst, Belgium

Henricus J. Duckers, MD, PhD
Erasmus University Hospital
Rotterdam, Netherlands

Amit Patel, MD, MS
University of Utah
Salt Lake City, Utah

Marc S. Penn, MD, PhD
Summa Health System
Cleveland, Ohio

WHEN: January 25-27, 2012

WHERE: Vivian and Seymour Milstein Family Heart Center
Myrna L. Daniels Auditorium
NYPH/Columbia University Medical Center
173 Fort Washington Avenue, 1st Floor
New York, NY 10032

For more information visit:

HOW TO REGISTER: Media may apply for registration by visiting


Contact: Judy Romero
Cardiovascular Research Foundation

Related medicine news :

1. Embedded Mobile & M2M Device revenues to Rise to Almost $19 Billion Globally by 2014, Says Juniper Research
2. International Diabetes Federation awards $2 million to 9 global diabetes research projects
3. Virtual Global Highlights Top Ten Misconceptions about Cloud Computing
4. Global Health Defined as Public Health in a New Lancet Commentary by the Association of Schools of Public Health (ASPH)
5. Dr Yaghouti of Global Laser Vision Receives Patient's Choice Award for 2009
6. Bioniche Achieves Two Additional Milestones Under Licensing Agreement; Endo Takes up Global Rights
7. Now Serving 9 Billion: A Global Town Hall
8. The Global Leaders' Inaugural Meeting a Resounding Success
9. Language Service Leader Expands to Meet Booming, Global Industry Demand.
10. GenomeQuest Hosts Seminar Focused On Web-based Searching for Patent Information Across Global Sequence Databases
11. Global Nutrition Firm Takes Dose of SonicWALL to Boost Network Health
Post Your Comments:
(Date:10/9/2015)... ... , ... Smoke alarms can save lives. In fact, according to the National ... reported home fires in half. As part of Fire Prevention Week, Amica Insurance ... maintained. , Half of home fire deaths result from fires reported between 11 p.m. ...
(Date:10/9/2015)... ... 2015 , ... Matrix IT Medical Tracking Systems LLC, a ... world’s first sterile field scanner. , The TRACTUS platform was developed, ... Unique Device Identifier (UDI) Final Rule, which will require manufacturers to directly mark ...
(Date:10/9/2015)... New Orleans, LA (PRWEB) , ... October 09, ... ... firm with offices serving New Orleans and the surrounding communities, is initiating a ... shelter and medical care for unwanted animals in southern Louisiana. , Animal ...
(Date:10/9/2015)... City, UT (PRWEB) , ... October 09, 2015 , ... ... Mental Illness Awareness Week. For many teenagers facing mental illness, the stigma associated with ... they need. , ViewPoint Center understands the importance of supporting teens with ...
(Date:10/9/2015)... ... October 09, 2015 , ... Amada ... recently opened its newest office in Maryland – its Bethesda location. ... background as a project management technology consultant to many of the largest construction ...
Breaking Medicine News(10 mins):
... The new Centers for Medicare & Medicaid Services ... for three hospital-acquired infections (HAIs) will be the ... and professionals sponsored by the Association for Professionals ... New CMS Regulation: Implications for Infection Prevention & ...
... Care Investment Trust Inc.,(NYSE: CRE ) today announced ... CIT, to Care,s Board of Directors, which increases the,number ... his capacity as President of Corporate Finance at CIT, ... business unit leaders,in assessing their go-to-market models, developing integrated ...
... the medical-surgical industry,s most ... CHICAGO, April 17 GHX today unveiled ... customizable, real-time access to the,medical-surgical industry,s most ... GHX Market Intelligence*. With GHX,MiShare, manufacturers can ...
... Sign language interpreting is one of the highest-risk professions ... by Rochester Institute of Technology. The research indicates that ... high-risk tasks conducted in industrial settings, including assembly line ... increase in the mental and cognitive stress of the ...
... based,organizations and Babies,R,Us to help prepare local moms for the arrival of ... ... local moms-to-be, April,showers takes on a whole new meaning as Anthem Blue ... Resource Center,(CRC) in Evansville, Indiana., Amid the traditional theme of pink ...
... the Pipeline, LIVINGSTON, N.J., April 17 ... that its wholly-owned,subsidiary, Genotec Nutritionals, Inc., a New ... the distribution of its branded,products and through custom ... several large transactions for the manufacture of,fish oil ...
Cached Medicine News:
(Date:10/9/2015)... Oct. 9, 2015 Regulatory affairs groups within medical ... --> --> These specialized groups are charged ... of global regulations pertaining to the development and marketing of ... groups largely rely on their own internal effectiveness and efficiencies ... --> --> Optimal ...
(Date:10/9/2015)... 9, 2015 ® ... einer Kolonoskopie im Rahmen eines Screenings, einer ... NOCT-Studie bewertete auch die Compliance, Sicherheit, Patientenakzeptanz ... ® ) an erwachsenen Patienten vergleicht, die ... einer beobachtenden oder einer diagnostischen Kolonoskopie unterziehen. ...
(Date:10/9/2015)... , October 9, 2015 ... of major players. --> India ... --> announces addition of 3 ... and 2020 forecasts for global markets as well ... along with analysis of major players. ...
Breaking Medicine Technology:
... in Mice Transgenic for Human TNFa, LAUSANNE, ... (Debiopharm), a global independent biopharmaceutical,development company specialising ... presentation of preclinical results that,validate the mechanism ... vaccine, that inhibits inflammatory processes in animal,models ...
... 2007 /PRNewswire-FirstCall/ --,InB:Biotechnologies, Inc. ("BioTech"), a wholly-owned ... strong positive,results in studies of vaccines against ... proprietary AIPwLV(TM) vaccine technology. The,studies were conducted ... (CMB), the Contract Research Organization led by ...
Cached Medicine Technology:
... The Self-Cath Closed System is a ... method for safe, simple catheterization designed ... tract infections. It includes a ... The new EasyOff tear tab makes ...
... The Self-Cath Closed System is a ... method for safe, simple catheterization designed ... tract infections. It includes a ... The new EasyOff tear tab makes ...
... Self-Cath family of 100% ... a variety of options ... Each catheter is made ... PVC and has smooth ...
... The Self-Cath family ... offers patients a variety ... self-catheterization. Each catheter ... medical grade PVC and ...
Medicine Products: